| 标题 |
ALIGN Phase 3 Primary Endpoint Analysis: Atrasentan Shows Significant Reduction in Proteinuria in Patients with IgA Nephropathy
ALIGN 3期主要终点分析：阿曲生坦显示IgA肾病患者蛋白尿显著减少
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | ALIGN Phase 3 Primary Endpoint Analysis: Atrasentan Shows Significant Reduction in Proteinuria in Patients with IgA Nephropathy. Presented at European Renal Association (ERA) Congress; May 25, 2024; Stockholm, Sweden. |
| 求助人 | |
| 下载 |
cdercder
bc
昏睡的蟠桃
SYLH
科研助手6
冰魂
iNk
椰子在长江送礼物
m木宁木蒙
等待的忆枫
pcr163
pluto
科研小民工
yufanhui
平常的毛豆
赫枫
高大凌寒
back you up
Thien
杀出个黎明
皖公网安备34019202002308
